(UHS) Universal Health - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9139031002
UHS EPS (Earnings per Share)
UHS Revenue
UHS: Hospitals, Medical Services, Behavioral Health, Insurance, Management Services
Universal Health Services Inc (NYSE:UHS) is a multifaceted healthcare provider operating through two primary segments: Acute Care Hospital Services and Behavioral Health Care Services. The companys diverse range of services includes general and specialty surgery, internal medicine, obstetrics, and emergency care, among others. Additionally, UHS provides commercial health insurance services and various management services such as central purchasing, information services, and physician recruitment to its subsidiaries and potentially external clients.
With a founding date of 1978 and headquartered in King of Prussia, Pennsylvania, UHS has established itself as a significant player in the healthcare industry. The companys operational footprint includes acute care hospitals and outpatient and behavioral health care facilities, indicating a broad reach into different aspects of healthcare provision.
Analyzing the available
From a fundamental perspective, UHS has a market capitalization of $12.17 billion and a P/E ratio of 10.60, with a forward P/E of 9.97. The Return on Equity (RoE) stands at 17.92%, suggesting a relatively strong profitability. Combining these insights, a forecast for UHS could involve a potential rebound from its current levels, driven by its undervaluation relative to its 52-week high and its robust RoE. If the stock can break through the SMA200 resistance at $196.42, it may be poised for further growth, potentially targeting the 52-week high of $240.75. However, a failure to break this resistance could result in continued volatility around the current price levels.
Based on the analysis, a possible trading strategy could involve monitoring UHS for a breakout above $196.42, with a potential target of $240.75, while keeping a close eye on the ATR for signs of increasing volatility that could either propel the stock upwards or downwards. Conversely, if the stock fails to gain traction and falls below its SMA50, it may signal a further decline, potentially towards the 52-week low.
Additional Sources for UHS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
UHS Stock Overview
Market Cap in USD | 11,068m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 1990-03-26 |
UHS Stock Ratings
Growth Rating | 33.5 |
Fundamental | 70.7 |
Dividend Rating | 34.7 |
Rel. Strength | -1.09 |
Analysts | 3.79 of 5 |
Fair Price Momentum | 168.99 USD |
Fair Price DCF | 396.30 USD |
UHS Dividends
Dividend Yield 12m | 0.44% |
Yield on Cost 5y | 0.85% |
Annual Growth 5y | 31.95% |
Payout Consistency | 56.8% |
Payout Ratio | 4.5% |
UHS Growth Ratios
Growth Correlation 3m | 7.6% |
Growth Correlation 12m | -57.3% |
Growth Correlation 5y | 68.6% |
CAGR 5y | 12.84% |
CAGR/Max DD 5y | 0.29 |
Sharpe Ratio 12m | 1.05 |
Alpha | -15.95 |
Beta | 0.536 |
Volatility | 28.91% |
Current Volume | 1572.5k |
Average Volume 20d | 695.9k |
As of June 23, 2025, the stock is trading at USD 171.70 with a total of 1,572,510 shares traded.
Over the past week, the price has changed by +0.79%, over one month by -7.91%, over three months by -5.34% and over the past year by -9.75%.
Yes, based on ValueRay´s Fundamental Analyses, Universal Health (NYSE:UHS) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 70.73 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UHS is around 168.99 USD . This means that UHS is currently overvalued and has a potential downside of -1.58%.
Universal Health has received a consensus analysts rating of 3.79. Therefor, it is recommend to hold UHS.
- Strong Buy: 7
- Buy: 1
- Hold: 11
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, UHS Universal Health will be worth about 182.9 in June 2026. The stock is currently trading at 171.70. This means that the stock has a potential upside of +6.52%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 225.4 | 31.3% |
Analysts Target Price | 225.3 | 31.2% |
ValueRay Target Price | 182.9 | 6.5% |